Positive Psychology in Cancer Care: A Story Line Resistant to Evidence | Annals of Behavioral Medicine
Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med. 2005; 353: 1673-1684. ...
Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-,...
... to neoadjuvant chemotherapy (NACT) for breast cancer, and further outline a predictive model of pCR combining DW MRI parameters ... Early Breast Cancer Trialists Collaborative G. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast ... NACT makes it possible to monitor the tumor response in vivo during treatment when compared with adjuvant chemotherapy. In ... Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States. Cancer. 2015;121:2544-52. ...
Determinants for patient satisfaction regarding aesthetic outcome and skin sensitivity after breast-conserving surgery | World...
... influence of type of tumour bed boost and adjuvant chemotherapy. Clin Oncol (R Coll Radiol). 2007;19:596-603. ... No patient received neoadjuvant chemotherapy. Adjuvant radiotherapy was administered to the remaining breast parenchyma: 50 Gy ... Chemotherapy and hormonal therapy were not associated with patient satisfaction in this study. Some previous studies have shown ... Surgery and adjuvant treatment. The surgeon chose operative method after discussing with the patient. Breast-conserving surgery ...
Colorectal cancer survivors only marginally change their overall lifestyle in the first 2 years following diagnosis | Journal...
... receipt of neo-adjuvant treatment, stoma placement after surgery, receipt of adjuvant chemotherapy, and presence of ... neo-adjuvant treatment, adjuvant chemotherapy, and comorbidities) and self-reported side-effects of treatment were included, ... Changes in body weight in patients with colorectal cancer treated with surgery and adjuvant chemotherapy: an observational ... as chemotherapy is usually not completed within 6 months after diagnosis and also recovery from surgery might not be complete ...
Application of artificial intelligence in nuclear medicine and molecular imaging: a review of current status and future...
Why should a patient accept receiving adjuvant chemotherapy if both the patient and the doctor do not understand the reasons ...
Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma | Radiation Oncology
... with concomitant and adjuvant temozolomide (TMZ) chemotherapy [3, 4]. Despite this multimodal therapeutical approach, the ... Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a ... in those studies concomitant and adjuvant TMZ was not yet standard-of-care for first line treatment of GBM, making their ... Timing of adjuvant radiotherapy in glioblastoma patients. Neurosurgery. 2016;78:676-82 https://doi.org/10.1227/NEU. ...
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with...
Despite the benefit of adjuvant hormonal therapy (HT) on mortality among women with breast cancer (BC), many women are non- ... Neugut AI, Matasar M, Wang X, McBride R, Jacobson JS, Tsai WY, Grann VR, Hershman DL (2006) Duration of adjuvant chemotherapy ... Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med 330(18):1253-1259 ... Racial disparity in the dose and dose intensity of breast cancer adjuvant chemotherapy. Breast Cancer Res Treat 81(1):21-31 ...
Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulence and Change | SpringerLink
Alternatively, IV chemotherapy dosing schedules that are every 3 weeks rather than weekly should be considered when appropriate ... It may be reasonable to shorten adjuvant therapy based on reasonable extrapolation of clinical trial data, or even completely ... Whether the modality employed is surgery, chemotherapy, radiation, or immunotherapy, the potential for exacerbation of lung ... guidelines recommend testing for COVID infection prior to chemotherapy infusions,3 although it is acknowledged that shortage of ...
The CIREL Cohort: A Prospective Controlled Registry Studying the Real-Life Use of Irinotecan-Loaded Chemoembolisation in...
... intra-arterial chemotherapy [23] and radioembolisation [1]. Additionally, systemic treatments including chemotherapy and ... In 20%, liver metastases had been resected with 4% of the total population having received adjuvant fluoropyrimidines and ... a first-line therapy for chemo-naïve or patients that have not received systemic chemotherapy after diagnosis of liver ... a "consolidation" treatment with or without systemic chemotherapy for patients that have a tumour response or a stable disease ...
Calories, carbohydrates, and cancer therapy with radiation: exploiting the five R's through dietary manipulation | Cancer and...
2012). The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS ONE, 7, ... 2012) Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Science Translational ... p53 is strongly connected to the Warburg phenotype [81] and provides a rationale for the use of cycle-dependent chemotherapy. ... Today, it constitutes the standard of care for many cancer patients, along with surgery and chemotherapy. Recently, treatment ...
Association of patterns of care, prognostic factors, and use of radiotherapy-temozolomide therapy with survival in patients...
6 cycles of adjuvant TMZ before progression. MS were estimated for each group, and we showed that prolonging the adjuvant ... Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data ... in the group of patients who received adjuvant TMZ, f continuation versus discontinuation of the adjuvant TMZ after 6 cycles as ... biopsy) in the group of patients who initiated (at least) the RT-TMZ, d treatment with versus without local chemotherapy ( ...
Peer Review reports | Treatment patterns and outcomes in older women with early breast cancer: a population-based cohort study...
However, adjuvant chemotherapy was associated with improved overall survival (OS) (hazard ratio [HR] 0.521, 95% confidence ... Elderly group patients were less likely to receive adjuvant chemotherapy or postmastectomy radiotherapy (PMRT) compared to the ... adjuvant chemotherapy, endocrine and targeted therapy are associated with improved OS in older breast cancer patients. Moreover ... Subgroup analysis revealed that patients with grade III disease best benefited from adjuvant chemotherapy. PMRT offered a ...
Nurse-led emergency department avoidance model of care for patients receiving cancer therapy in the ambulatory setting: a...
All patients were receiving SACT and were identified based on chemotherapy activity (receiving cycle 2 or 3 of chemotherapy) ... to improve efficiency and quality of care for breast cancer patients receiving adjuvant therapy. Asia - Pacific Journal of ... Chemotherapy outpatients unplanned presentations to hospital: a retrospective study. Support Care Cancer. 2011;19(7):963-9. ... While the initial design of the SURC model included pre-chemotherapy education, local adaptation at each site resulted in ...
Neoadjuvant Chemoradiation Versus Upfront Esophagectomy in Clinical Stage II and III Esophageal Squamous Cell Carcinoma |...
Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III ... A propensity-matched analysis comparing survival after esophagectomy followed by adjuvant chemoradiation to surgery alone for ... A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to ... Upfront surgery and pathological stage-based adjuvant chemoradiation strategy in locally advanced esophageal squamous cell ...
Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched...
In Austria, nabilone is licensed for the use as an antiemetic for chemotherapy-induced nausea and vomiting not responding to ... parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain. Pain 153: ...